These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6601057)

  • 21. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.
    Fernandez N; Kurpisz M; Labeta M; Sachs J; Pawelec G
    Immunology; 1992 Sep; 77(1):116-22. PubMed ID: 1383136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant.
    Gladstone P; Pious D
    Somatic Cell Genet; 1980 Mar; 6(2):285-98. PubMed ID: 6967232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies.
    Misko IS; Pope JH; Hütter R; Soszynski TD; Kane RG
    Int J Cancer; 1984 Feb; 33(2):239-43. PubMed ID: 6319303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisera recognising HLA-A, -B and DRW antigens raised in rhesus monkeys.
    Barnstable CJ; Snary D; Crumpton MJ; Balner H; Bodmer WF
    Tissue Antigens; 1980 May; 15(5):407-18. PubMed ID: 6160645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptides recognized by class I restricted T cells also bind to MHC class II molecules.
    Hickling JK; Fenton CM; Howland K; Marsh SG; Rothbard JB
    Int Immunol; 1990; 2(5):435-41. PubMed ID: 2085488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.
    Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
    J Immunol; 1983 Jul; 131(1):152-7. PubMed ID: 6190904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
    Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
    Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human helper-dependent influenza virus-specific cytotoxic T lymphocyte clone restricted by HLA-DR2.
    Fleischer B
    Tissue Antigens; 1985 Oct; 26(4):248-53. PubMed ID: 2933850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
    Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-dependent cell-mediated cytotoxicity against HLA-A, HLA-B and HLA-DR specificities.
    Akiyama N; Ohsawa N; Kano K
    Int Arch Allergy Appl Immunol; 1984; 74(3):286-8. PubMed ID: 6327536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes.
    Palacios R; Martinez-Maza O; Guy K
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3456-60. PubMed ID: 6222380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.